{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/697cc123ebb1ff695f473b17?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit","description":"<p>We kick off the very first episode of 2026 with a major legal development. This week, the former CEO of CytoDyn was sentenced to 30 months in prison, more than a year after being convicted on multiple charges including four counts of securities fraud, two counts of wire fraud, and three counts of insider trading. Also, we examine recent investments in artificial intelligence by several major drugmakers, and where they are hoping the technology can make an impact. Then, the latest from 10x Genomics and its plans to expand into clinical diagnostics through new collaboration. And for some research news, a new study that explores how functional forms of amyloid can create stable memories.</p><p>&nbsp;</p><p>Join <em>GEN</em> editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.&nbsp;</p><p>Listed below are links to the <em>GEN</em> stories referenced in this episode of <em>Touching Base</em>:&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/infectious-diseases/ex-cytodyn-ceo-sentenced-to-30-month-prison-term-on-fraud-insider-trading/\" rel=\"noopener noreferrer\" target=\"_blank\">Ex-CytoDyn CEO Sentenced to 30-Month Prison Term on Fraud, Insider Trading</a></p><p>By Alex Philippidis, <em>GEN</em>, January 27, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/pharma-bets-big-on-ai-platforms-with-flurry-of-new-year-deals/\" rel=\"noopener noreferrer\" target=\"_blank\">Pharma Bets Big on AI Platforms with Flurry of New Year Deals</a></p><p>By Fay Lin, PhD, <em>GEN Edge</em>, January 22, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/jpm-nvidia-launches-ai-collaborations-with-eli-lilly-thermo-fisher/\" rel=\"noopener noreferrer\" target=\"_blank\">JPM: Nvidia Launches AI Collaborations with Eli Lilly, Thermo Fisher</a></p><p>By Alex Philippidis, <em>GEN Edge</em>, January 13, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/omics/clinical-ambitions-10x-expands-beyond-research-with-trio-of-collaborations/\" rel=\"noopener noreferrer\" target=\"_blank\">Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations</a></p><p>By Alex Philippidis, <em>GEN Edge</em>, January 26, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/chais-the-limit-for-ai-antibody-designer-after-130m-series-b-funding/\" rel=\"noopener noreferrer\" target=\"_blank\">Chai’s the Limit for AI Antibody Designer After $130M Series B Funding</a></p><p>By Alex Philippidis, <em>GEN Edge</em>, December 16, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/lilly-expands-ai-ties-to-insilico-from-customer-to-drug-discovery-partner/\" rel=\"noopener noreferrer\" target=\"_blank\">Lilly Expands AI Ties to Insilico, from Customer to Drug Discovery Partner</a></p><p>By Alex Philippidis, <em>GEN Edge</em>, November 10, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/translational-medicine/how-brain-may-deliberately-form-amyloids-to-turn-experiences-into-memories/\" rel=\"noopener noreferrer\" target=\"_blank\">How Brain May Deliberately Form Amyloids to Turn Experiences Into Memories</a></p><p><em>GEN</em>, January 26, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/category/multimedia/podcasts/touching-base/\" rel=\"noopener noreferrer\" target=\"_blank\">Touching Base Podcast</a>&nbsp;</p><p>Hosted by Corinna Singleman, PhD&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.insideprecisionmedicine.com/category/multimedia/podcasts/\" rel=\"noopener noreferrer\" target=\"_blank\">Behind the Breakthroughs</a>&nbsp;</p><p>Hosted by Jonathan D. Grinstein, PhD&nbsp;</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}